Mount Sinai Fuster Heart Hospital (New York, USA) has announced the launch of the Samuel Fineman Cardiac Catheterization Artificial Intelligence (AI) Research Lab.
Led by Annapoorna Kini, the lab will focus on a wide range of aspects of interventional cardiology, from procedural to educational, to gather new insights that can make a significant impact on how health care is delivered. From risk stratification to case planning, optimising outcomes, and more, artificial intelligence has the capability to spur whole new levels of innovation, the organisation says in a press release.
“While AI is not a magic solution to every problem, there are many places it can make a notable improvement over traditional techniques or bring some approaches that were never possible within reach. In five or so years, we think that many workflows can be augmented by AI to better focus our resources where they are most needed,” says Kini.
“In our cath lab at Mount Sinai, we have always been at the forefront of using rapidly evolving AI technologies to advance patient care. We have already implemented AI applications to augment patient engagement and care coordination, and we are now moving to the next level by integrating AI technologies in our research and clinical work.
“As an early adopter in adapting to a future with AI, we plan to continue to be a leader in embedding AI in our processes and work flows to achieve even better outcomes for our patients.”
